nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—OPRL1—Peptide GPCRs—CXCR3—alopecia areata	0.0605	0.0605	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—CXCL9—alopecia areata	0.0441	0.0441	CbGpPWpGaD
Buprenorphine—OPRL1—G alpha (i) signalling events—CXCL9—alopecia areata	0.0372	0.0372	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CXCL9—alopecia areata	0.0296	0.0296	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—CXCR3—alopecia areata	0.0284	0.0284	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide GPCRs—CXCR3—alopecia areata	0.0258	0.0258	CbGpPWpGaD
Buprenorphine—OPRL1—G alpha (i) signalling events—CXCR3—alopecia areata	0.024	0.024	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—CXCL10—alopecia areata	0.023	0.023	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide GPCRs—CXCR3—alopecia areata	0.0226	0.0226	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—CXCL9—alopecia areata	0.0225	0.0225	CbGpPWpGaD
Buprenorphine—OPRL1—GPCRs, Class A Rhodopsin-like—CXCR3—alopecia areata	0.0223	0.0223	CbGpPWpGaD
Buprenorphine—OPRL1—G alpha (i) signalling events—CXCL10—alopecia areata	0.0194	0.0194	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide GPCRs—CXCR3—alopecia areata	0.0191	0.0191	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CXCR3—alopecia areata	0.0191	0.0191	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—CXCL9—alopecia areata	0.0188	0.0188	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—CXCL9—alopecia areata	0.0165	0.0165	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—CXCL9—alopecia areata	0.0159	0.0159	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CXCL10—alopecia areata	0.0154	0.0154	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—CXCR3—alopecia areata	0.0145	0.0145	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CXCL9—alopecia areata	0.014	0.014	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—CXCL9—alopecia areata	0.0139	0.0139	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CXCL9—alopecia areata	0.0132	0.0132	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—CXCL9—alopecia areata	0.0127	0.0127	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL9—alopecia areata	0.0126	0.0126	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—CXCR3—alopecia areata	0.0121	0.0121	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—CXCL9—alopecia areata	0.0118	0.0118	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—CXCL10—alopecia areata	0.0117	0.0117	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CXCL9—alopecia areata	0.0116	0.0116	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—CD8A—alopecia areata	0.0112	0.0112	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL9—alopecia areata	0.0111	0.0111	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—CXCR3—alopecia areata	0.0106	0.0106	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—CXCR3—alopecia areata	0.0102	0.0102	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—CXCL10—alopecia areata	0.00981	0.00981	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CXCL9—alopecia areata	0.00962	0.00962	CbGpPWpGaD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—alopecia areata	0.0095	0.0095	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL9—alopecia areata	0.00936	0.00936	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CXCR3—alopecia areata	0.009	0.009	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—CXCR3—alopecia areata	0.00898	0.00898	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—CXCL10—alopecia areata	0.0086	0.0086	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CXCL9—alopecia areata	0.00844	0.00844	CbGpPWpGaD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—alopecia areata	0.00833	0.00833	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—CXCL10—alopecia areata	0.00828	0.00828	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—CXCR3—alopecia areata	0.00821	0.00821	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—alopecia areata	0.00814	0.00814	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CTLA4—alopecia areata	0.00759	0.00759	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—CXCR3—alopecia areata	0.00759	0.00759	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CXCR3—alopecia areata	0.00745	0.00745	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CXCL10—alopecia areata	0.00727	0.00727	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—CXCL10—alopecia areata	0.00726	0.00726	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—alopecia areata	0.00714	0.00714	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCL9—alopecia areata	0.00713	0.00713	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—alopecia areata	0.00704	0.00704	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCL9—alopecia areata	0.00683	0.00683	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—CXCL10—alopecia areata	0.00663	0.00663	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—alopecia areata	0.00658	0.00658	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—CD4—alopecia areata	0.00644	0.00644	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CXCR3—alopecia areata	0.0062	0.0062	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—CXCL10—alopecia areata	0.00613	0.00613	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—alopecia areata	0.00603	0.00603	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CXCL10—alopecia areata	0.00603	0.00603	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—alopecia areata	0.00577	0.00577	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCL9—alopecia areata	0.00544	0.00544	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CXCR3—alopecia areata	0.00544	0.00544	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL2RA—alopecia areata	0.00526	0.00526	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—IL2RA—alopecia areata	0.00507	0.00507	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CXCL10—alopecia areata	0.00501	0.00501	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCL9—alopecia areata	0.00494	0.00494	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—alopecia areata	0.00488	0.00488	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL9—alopecia areata	0.00477	0.00477	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL2RA—alopecia areata	0.00461	0.00461	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCR3—alopecia areata	0.00459	0.00459	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCR3—alopecia areata	0.0044	0.0044	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CXCL10—alopecia areata	0.00439	0.00439	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL9—alopecia areata	0.00433	0.00433	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL9—alopecia areata	0.00403	0.00403	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCL10—alopecia areata	0.00371	0.00371	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL9—alopecia areata	0.00366	0.00366	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCL10—alopecia areata	0.00356	0.00356	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCR3—alopecia areata	0.0035	0.0035	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCR3—alopecia areata	0.00318	0.00318	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCR3—alopecia areata	0.00307	0.00307	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL9—alopecia areata	0.00292	0.00292	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCL10—alopecia areata	0.00283	0.00283	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCR3—alopecia areata	0.00279	0.00279	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL2RA—alopecia areata	0.00272	0.00272	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCR3—alopecia areata	0.0026	0.0026	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCL10—alopecia areata	0.00257	0.00257	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL9—alopecia areata	0.00256	0.00256	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL10—alopecia areata	0.00248	0.00248	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCR3—alopecia areata	0.00236	0.00236	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL10—alopecia areata	0.00226	0.00226	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2RA—alopecia areata	0.00216	0.00216	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL9—alopecia areata	0.00216	0.00216	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL10—alopecia areata	0.0021	0.0021	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2RA—alopecia areata	0.00197	0.00197	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL10—alopecia areata	0.00191	0.00191	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2RA—alopecia areata	0.0019	0.0019	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCR3—alopecia areata	0.00188	0.00188	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2RA—alopecia areata	0.00172	0.00172	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCR3—alopecia areata	0.00165	0.00165	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2RA—alopecia areata	0.0016	0.0016	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL10—alopecia areata	0.00152	0.00152	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2RA—alopecia areata	0.00146	0.00146	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCR3—alopecia areata	0.00139	0.00139	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL10—alopecia areata	0.00133	0.00133	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2RA—alopecia areata	0.00116	0.00116	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL10—alopecia areata	0.00113	0.00113	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2RA—alopecia areata	0.00102	0.00102	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2RA—alopecia areata	0.000861	0.000861	CbGpPWpGaD
